Xueni Liu

机构：Nanjing Children's Hospital, Lishui Central Hospital · ORCID：0000-0002-8193-7246

发表论文 64 篇 · 总被引 871 次 · h-index 17

代表论文

• Global burden of primary liver cancer by five etiologies and global prediction by 2035 based on global burden of disease study 2019 (2022 · Cancer Medicine · 被引 124)
• Dynamic immune recovery process after liver transplantation revealed by single-cell multi-omics analysis (2024 · The Innovation · 被引 22)
• Hepatic pannexin‐1 mediates ST2+ regulatory T cells promoting resolution of inflammation in lipopolysaccharide‐induced endotoxemia (2022 · Clinical and Translational Medicine · 被引 21)
• MSI2 deficiency in ILC3s attenuates DSS-induced colitis by affecting the intestinal microbiota (2023 · Frontiers in Immunology · 被引 15)
• Clinical characteristics and treatment efficacy of immune checkpoint inhibitors (ICIs) in patients with ICIs-induced Adrenal insufficiency (2023 · Translational Oncology · 被引 14)
• Identification of Therapeutic Targets and Prognostic Biomarkers Among Chemokine (C-C Motif) Ligands in the Liver Hepatocellular Carcinoma Microenvironment (2021 · Frontiers in Cell and Developmental Biology · 被引 12)